Position statements

Evidence-based clinical guidance for myeloma diagnosis & management. Expert-authored resources to support health professionals in patient care.

This resource hub provides clinicians with practical, evidence-based guidance for the diagnosis and management of multiple myeloma and related conditions.

From clinical practice guidelines to position statements, the Medical and Scientific Advisory Group (MSAG) author these documents to support health professionals in delivering patient care.

MSAG position statements and notable publications

Bisphosphonate guidelines treatment prevention

This position statement provides guidance on the safe and effective use of bisphosphonates for managing myeloma bone disease, balancing treatment benefits with potential risks.

COVID19 LPD and MM consensus

a guide for haematologists on how to safely adapt lymphoma, CLL, and myeloma treatments during COVID-19.

GP journal article

A practical guide for general practitioners on recognising, diagnosing and managing multiple myeloma, with an emphasis on early detection, shared care and improving patient outcomes.

IMJ position statement for transplant eligible

Evidence‑based guidance on the use of high‑dose chemotherapy and autologous stem cell transplantation in the initial treatment of multiple myeloma, including induction, conditioning and maintenance therapy.

IMJ the importance of frailty assessment in multiple myeloma

Guidance on the use of frailty assessment tools to inform personalised treatment in multiple myeloma.

Telephone Support Line

Talk directly with our specialist myeloma nurses who understand exactly what you’re going through.

Use our simple booking form below to schedule your personalised consultation at a time that works for you.

Get the expert guidance and emotional support you need, when you need it most.

Person holding a smartphone while enjoying a hot drink near a bright window, suggesting a relaxed moment of connection or communication.